Advancing the Future of Precision Cancer Care

Invest in Ayutara Therapeutics through Regulation CF and support the development of targeted radiopharmaceutical therapies designed to transform oncology outcomes.

Explore the Opportunity

Why Crowdfunded Investing Matters

Regulation Crowdfunding (Reg CF) enables individuals to invest directly in innovative biotech companies like Ayutara—backing science with real-world impact.

Open to Everyday Investors

Participate as a non-accredited investor with accessible minimum investment thresholds.

Regulatory Transparency

SEC-regulated fundraising with defined disclosures, compliance, and investor protection.

Equity Participation

Gain ownership in Ayutara Therapeutics and share in long-term value creation.

Your Path to Investing in Ayutara

Step 1: Create Your Account

Register on our approved crowdfunding platform partner to access the offering.

1

Step 2: Evaluate the Offering

Review Form C, development roadmap, financial disclosures, and risk factors.

2

Step 3: Complete Your Investment

Select your investment amount and securely finalize your participation.

3

Step 4: Track Our Progress

Receive ongoing updates on scientific milestones and company advancements.

4

Why Invest in Ayutara Therapeutics

Scientific Advancement

Support the development of targeted radiopharmaceutical solutions in oncology.

Growth Potential

Participate in value creation as programs advance toward clinical milestones.

Early Access Advantage

Receive investor communications, insights, and milestone-based updates

Meaningful Impact

Join a mission-driven effort to improve cancer treatment precision worldwide.

Our Current Offering

Regulation CF Campaign

Target Raise $1,000,000 to advance ATX-101 toward IND filing

Minimum Investment: $250

Share Price: $5 per share

View Offering Details Investing involves risk, including possible loss of principal. Review all disclosures carefully before investing.

Frequently Asked Questions

Regulation Crowdfunding allows eligible companies to raise capital from the public through SEC-registered platforms, including non-accredited investors.

Biotechnology investments carry scientific, regulatory, and market risks, including the possibility of delayed development or loss of capital.

Investors receive regular progress updates through official platform communications and email notifications.

RBe Part of the Next Breakthrough

Join Ayutara Therapeutics in advancing precision oncology through innovative radiopharmaceutical science.

IInvest Today